These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 32003968)

  • 1. In Situ Study of Interactions between Endogenous c-
    Yu S; Li F; Huang X; Dong C; Ren J
    Anal Chem; 2020 Feb; 92(4):2988-2996. PubMed ID: 32003968
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CRDBP Protein Phase Separation and Its Recruitment to β-Catenin Protein in a Single Living Cell.
    Liu J; Yu S; Yu W; Dong C; Huang X; Ren J
    J Phys Chem B; 2023 Dec; 127(49):10498-10507. PubMed ID: 38051203
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Objective scanning-based fluorescence cross-correlation spectroscopy (Scan-FCCS) for studying the fusion dynamics of protein phase separation.
    Liu J; Yu W; Dong C; Huang X; Ren J
    Analyst; 2024 Apr; 149(9):2719-2727. PubMed ID: 38525957
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular insights into the coding region determinant-binding protein-RNA interaction through site-directed mutagenesis in the heterogeneous nuclear ribonucleoprotein-K-homology domains.
    Barnes M; van Rensburg G; Li WM; Mehmood K; Mackedenski S; Chan CM; King DT; Miller AL; Lee CH
    J Biol Chem; 2015 Jan; 290(1):625-39. PubMed ID: 25389298
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of GLI1 Expression by Targeting the CRD-BP-GLI1 mRNA Interaction Using a Specific Oligonucleotide.
    Mehmood K; Akhtar D; Mackedenski S; Wang C; Lee CH
    Mol Pharmacol; 2016 Jun; 89(6):606-17. PubMed ID: 27036131
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of c-myc expression in cells by targeting an RNA-protein interaction using antisense oligonucleotides.
    Coulis CM; Lee C; Nardone V; Prokipcak RD
    Mol Pharmacol; 2000 Mar; 57(3):485-94. PubMed ID: 10692488
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CRD-BP shields c-myc and MDR-1 RNA from endonucleolytic attack by a mammalian endoribonuclease.
    Sparanese D; Lee CH
    Nucleic Acids Res; 2007; 35(4):1209-21. PubMed ID: 17264115
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Purification and properties of a protein that binds to the C-terminal coding region of human c-myc mRNA.
    Prokipcak RD; Herrick DJ; Ross J
    J Biol Chem; 1994 Mar; 269(12):9261-9. PubMed ID: 8132663
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hinge like domain motion facilitates human RBMS1 protein binding to proto-oncogene c-myc promoter.
    Aggarwal P; Bhavesh NS
    Nucleic Acids Res; 2021 Jun; 49(10):5943-5955. PubMed ID: 33999211
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In Situ Monitoring of p53 Protein and MDM2 Protein Interaction in Single Living Cells Using Single-Molecule Fluorescence Spectroscopy.
    Du Z; Yu J; Li F; Deng L; Wu F; Huang X; Bergstrand J; Widengren J; Dong C; Ren J
    Anal Chem; 2018 May; 90(10):6144-6151. PubMed ID: 29671327
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CRD-BP: a c-Myc mRNA stabilizing protein with an oncofetal pattern of expression.
    Ioannidis P; Mahaira L; Papadopoulou A; Teixeira MR; Heim S; Andersen JA; Evangelou E; Dafni U; Pandis N; Trangas T
    Anticancer Res; 2003; 23(3A):2179-83. PubMed ID: 12894594
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Avoiding false-positive signals with nuclease-vulnerable molecular beacons in single living cells.
    Chen AK; Behlke MA; Tsourkas A
    Nucleic Acids Res; 2007; 35(16):e105. PubMed ID: 17702767
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of domains in apobec-1 complementation factor required for RNA binding and apolipoprotein-B mRNA editing.
    Mehta A; Driscoll DM
    RNA; 2002 Jan; 8(1):69-82. PubMed ID: 11871661
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of c-Myc-RBM38 loop in the growth suppression in breast cancer.
    Li XX; Shi L; Zhou XJ; Wu J; Xia TS; Zhou WB; Sun X; Zhu L; Wei JF; Ding Q
    J Exp Clin Cancer Res; 2017 Apr; 36(1):49. PubMed ID: 28399911
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of endogenous K-ras mRNA in living cells at a single base resolution by a PNA molecular beacon.
    Kam Y; Rubinstein A; Nissan A; Halle D; Yavin E
    Mol Pharm; 2012 Mar; 9(3):685-93. PubMed ID: 22289057
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure of a construct of a human poly(C)-binding protein containing the first and second KH domains reveals insights into its regulatory mechanisms.
    Du Z; Fenn S; Tjhen R; James TL
    J Biol Chem; 2008 Oct; 283(42):28757-66. PubMed ID: 18701464
    [TBL] [Abstract][Full Text] [Related]  

  • 17. mrtl-A translation/localization regulatory protein encoded within the human c-myc locus and distributed throughout the endoplasmic and nucleoplasmic reticular network.
    Choi H; Jackson NL; Shaw DR; Emanuel PD; Liu YL; Tousson A; Meng Z; Blume SW
    J Cell Biochem; 2008 Nov; 105(4):1092-108. PubMed ID: 18816594
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiple androgen response elements and a Myc consensus site in the androgen receptor (AR) coding region are involved in androgen-mediated up-regulation of AR messenger RNA.
    Grad JM; Dai JL; Wu S; Burnstein KL
    Mol Endocrinol; 1999 Nov; 13(11):1896-911. PubMed ID: 10551783
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The structure of the ARE-binding domains of Hu antigen R (HuR) undergoes conformational changes during RNA binding.
    Wang H; Zeng F; Liu Q; Liu H; Liu Z; Niu L; Teng M; Li X
    Acta Crystallogr D Biol Crystallogr; 2013 Mar; 69(Pt 3):373-80. PubMed ID: 23519412
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comprehensive in vivo identification of the c-Myc mRNA protein interactome using HyPR-MS.
    Spiniello M; Steinbrink MI; Cesnik AJ; Miller RM; Scalf M; Shortreed MR; Smith LM
    RNA; 2019 Oct; 25(10):1337-1352. PubMed ID: 31296583
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.